These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 711442)

  • 1. Protection of the ischemic myocardium.
    Braunwald E
    Harvey Lect; 1978; 71():247-82. PubMed ID: 711442
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of ischemic myocardium.
    Armstrong PW
    Can Med Assoc J; 1977 Oct; 117(7):713-6. PubMed ID: 907938
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the effect of a left ventricular assist device on the left ventricular myocardium].
    Wei CM; Kusagawa M
    Zhonghua Yi Xue Za Zhi; 1988 Mar; 68(3):144-6, 12. PubMed ID: 3136892
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myocardial viability].
    Vacheron A
    Arch Mal Coeur Vaiss; 1997 Jul; 90 Spec No 4():9-10. PubMed ID: 9382699
    [No Abstract]   [Full Text] [Related]  

  • 5. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R; Vogt A; Schaper W
    Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of intra-aortic balloon counterpulsation on the hemodynamics and the metabolism of the non-ischemic and ischemic left heart ventricle].
    Vogel I; Krause EG; Kloppick E; Schneider M; Wollenberger A
    Z Exp Chir; 1973; 6(5):290-306. PubMed ID: 4792196
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physiopathological basis of protection of the ischemic myocardium].
    Lerch R; Benzi R
    Schweiz Med Wochenschr; 1990 Oct; 120(42):1523-30. PubMed ID: 2237340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
    Skyschally A; Schulz R; Heusch G
    Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage.
    Kloner RA; Ellis SG; Lange R; Braunwald E
    Circulation; 1983 Aug; 68(2 Pt 2):I8-15. PubMed ID: 6861331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
    Schwartz LM; Sebbag L; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Model of reinfarction of the myocardium in animals and characteristics of electrocardiographic changes].
    Eĭdinov IaB
    Vrach Delo; 1967; 9():36-9. PubMed ID: 5621776
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathophysiology of reperfusion of the ischemic myocardium].
    Wu GL
    Sheng Li Ke Xue Jin Zhan; 1983 Apr; 14(2):118-22. PubMed ID: 6612294
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical changes in non-infarcted heart muscle following myocardial infarction.
    Gudbjarnason S; Mathes P
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():581-9. PubMed ID: 4806989
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible electrophysiological mechanisms for lethal arrhythmias accompanying myocardial ischemia and infarction.
    Wit AL; Bigger JT
    Circulation; 1975 Dec; 52(6 Suppl):III96-115. PubMed ID: 1182986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of the size of the ischemic area on the beneficial effects of drugs capable of protecting the ischemic myocardium].
    Ribeiro LG; Faria DB; Cheung WM; Maroko PR
    Arq Bras Cardiol; 1982 Nov; 39(5):297-301. PubMed ID: 7186382
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarction.
    Lynch JJ; Wallace AA; Stump GL; Stupienski RF; Kothstein T; Gehret JR
    J Pharmacol Exp Ther; 1996 May; 277(2):671-8. PubMed ID: 8627544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothermic synchronized retroperfusion of the coronary veins for the treatment of acutely ischemic myocardium.
    Haendchen RV; Corday E; Meerbaum S
    Compr Ther; 1982 Dec; 8(12):7-15. PubMed ID: 7160165
    [No Abstract]   [Full Text] [Related]  

  • 20. [Verification of myocardial viability: MRI is already the standard today--pro].
    Nagel E
    Dtsch Med Wochenschr; 2007 Apr; 132(14):746. PubMed ID: 17393346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.